The current advice is to switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase
Understanding GLP-1 medications
The findings confirmed that the benefits seen at 40 weeks were sustained, with consistent HbA1c reductions and weight loss maintained through the two-year mark
Underneath all of this sits a subtler change that I find the most interesting of all
Denials are frequently reversed on the strength of documentation rather than on new clinical facts, so what your provider submits matters more than how often you resubmit
Led by Thomas Wadden, PhD, a professor at the University of Pennsylvania, the research reviewed findings from the Semaglutide Treatment Effect in People with Obesity (STEP) trials, which played a key role in the FDAs approval of semaglutide injections